Showing posts with label prognosis research journals. Show all posts
Showing posts with label prognosis research journals. Show all posts

Monday, 3 October 2016

The Utility and Applicability of Chronic Myeloid Leukemia Scoring Systems for Predicting the Prognosis of Egyptian Patients on Imatinib

Chronic myeloid leukemia (CML) is myeloproliferative clonal neoplasm with pluripotent hematopoietic stem cell origin. BCR-ABL fusion gene results from a balanced reciprocal translocation between BCR (Breakpoint cluster region) and ABL (Abelson) genes is the main finding in CML.

Chronic Myeloid Leukemia
Transposition of ABL proto-oncogene from chromosome 9 to BCR on chromosome 22 is either at chromosome level [Philadelphia (Ph) chromosome t(9;22)(q34;q11)] or cryptic at gene level. BCR-ABL encodes an unregulated, cytoplasm-targeted tyrosine kinase, leading to uninhibited cell proliferation.

CML is a triphasic disease, chronic-phase (CP), accelerated-phase (AP), and blast-phase (BP). Most patients are asymptomatic and diagnosed in CP; most patients will progress to rapidly fatal BP within 3–5 years if untreated.

Thursday, 15 September 2016

Rectal Cancer Following Neoadjuvant Radiochemotherapy

The prognosis of patients with rectal cancer is generally assessed using the TNM staging system, which stages lymph node involvement according to the absolute number of involved lymph nodes. Positive lymph nodes affect the prognosis of patients. Some research has indicated that the survival of patients with positive lymph nodes is much poorer. The 7th AJCC staging system divide patients with rectal cancer into four stages (N1a, N1b, N2a, N2b) which is more accurate than the 6th staging system, suggesting patients with more positive lymph nodes have unfavorable prognosis.

Neoadjuvant Radiochemotherapy
TNM staging system suggests more than 12 lymph node harvest is the premise of accurate N stage. However, adequate lymph nodes could be harvested in only approximate 1/3 patients of rectal cancer. Moreover, most of the patients with positive lymph nodes receive neoadjuvant radiotherapy which will reduce the number of lymph nodes harvest. It is difficult for the patients who have received preoperative radiotherapy to get adequate lymph nodes. The reduction of lymph node harvest may decrease patients’ prognosis and may not be reflected in TNM staging system. It affects prognosis value of N stage for these patients. Some researchers are searching for a more effective indicator to evaluate the situation of lymph nodes.


The lymph node ratio (LNR), the number of metastatic lymph nodes divided by the total number of examined nodes, might be a suitable staging system. LNR doesn’t depend on the absolute number of positive lymph nodes. It treats the ratio of positive lymph node as the indicator of lymph node metastasis. Although it has many drawbacks such as different cutoff values and inconsistent pathological evaluation, researchers focus on it as a valuable prognosis indicator.